ACB
Price
$3.74
Change
+$0.01 (+0.27%)
Updated
Sep 11 closing price
Capitalization
237.08M
60 days until earnings call
Intraday BUY SELL Signals
SNDL
Price
$1.34
Change
-$0.00 (-0.00%)
Updated
Sep 11 closing price
Capitalization
329.8M
59 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

ACB vs SNDL

ACB vs SNDL Comparison Chart in %
View a ticker or compare two or three
VS
ACB vs. SNDL commentary
Sep 12, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ACB is a Hold and SNDL is a Hold.

Interact to see
Advertisement
SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
SNDL($330M) has a higher market cap than ACB($237M). ACB YTD gains are higher at: -11.374 vs. SNDL (-19.277). SNDL has higher annual earnings (EBITDA): 39.6M vs. ACB (-34.12M). SNDL has more cash in the bank: 187M vs. ACB (100M). ACB has less debt than SNDL: ACB (22.7M) vs SNDL (166M). SNDL has higher revenues than ACB: SNDL (928M) vs ACB (314M).
ACBSNDLACB / SNDL
Capitalization237M330M72%
EBITDA-34.12M39.6M-86%
Gain YTD-11.374-19.27759%
P/E Ratio19.44N/A-
Revenue314M928M34%
Total Cash100M187M53%
Total Debt22.7M166M14%
FUNDAMENTALS RATINGS
ACB vs SNDL: Fundamental Ratings
ACB
SNDL
OUTLOOK RATING
1..100
1531
VALUATION
overvalued / fair valued / undervalued
1..100
46
Fair valued
42
Fair valued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
9691
PRICE GROWTH RATING
1..100
4561
P/E GROWTH RATING
1..100
8788
SEASONALITY SCORE
1..100
5085

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

SNDL's Valuation (42) in the null industry is in the same range as ACB (46) in the Pharmaceuticals Other industry. This means that SNDL’s stock grew similarly to ACB’s over the last 12 months.

SNDL's Profit vs Risk Rating (100) in the null industry is in the same range as ACB (100) in the Pharmaceuticals Other industry. This means that SNDL’s stock grew similarly to ACB’s over the last 12 months.

SNDL's SMR Rating (91) in the null industry is in the same range as ACB (96) in the Pharmaceuticals Other industry. This means that SNDL’s stock grew similarly to ACB’s over the last 12 months.

ACB's Price Growth Rating (45) in the Pharmaceuticals Other industry is in the same range as SNDL (61) in the null industry. This means that ACB’s stock grew similarly to SNDL’s over the last 12 months.

ACB's P/E Growth Rating (87) in the Pharmaceuticals Other industry is in the same range as SNDL (88) in the null industry. This means that ACB’s stock grew similarly to SNDL’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
ACBSNDL
RSI
ODDS (%)
Bearish Trend 2 days ago
81%
Bearish Trend 2 days ago
88%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
72%
Bullish Trend 2 days ago
73%
Momentum
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
85%
MACD
ODDS (%)
Bearish Trend 2 days ago
89%
Bearish Trend 2 days ago
80%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
87%
Bearish Trend 2 days ago
81%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
77%
Bullish Trend 2 days ago
74%
Advances
ODDS (%)
Bullish Trend 25 days ago
76%
Bullish Trend 5 days ago
70%
Declines
ODDS (%)
Bearish Trend 10 days ago
85%
Bearish Trend 3 days ago
82%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
90%
Bearish Trend 2 days ago
85%
Aroon
ODDS (%)
Bullish Trend 2 days ago
82%
Bullish Trend 2 days ago
72%
COMPARISON
Comparison
Sep 12, 2026
Stock price -- (ACB: $3.74 vs. SNDL: $1.34)
Brand notoriety: ACB: Notable vs. SNDL: Not notable
ACB represents the Pharmaceuticals: Generic, while SNDL is part of the Beverages: Alcoholic industry
Current volume relative to the 65-day Moving Average: ACB: 48% vs. SNDL: 151%
Market capitalization -- ACB: $237.08M vs. SNDL: $329.8M
ACB [@Pharmaceuticals: Generic] is valued at $237.08M. SNDL’s [@Beverages: Alcoholic] market capitalization is $329.8M. The market cap for tickers in the [@Pharmaceuticals: Generic] industry ranges from $2.12K to $63.66B. The market cap for tickers in the [@Beverages: Alcoholic] industry ranges from $1.5K to $19.33T. The average market capitalization across the [@Pharmaceuticals: Generic] industry is $4B. The average market capitalization across the [@Beverages: Alcoholic] industry is $5.48B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ACB’s FA Score shows that 0 FA rating(s) are green while SNDL’s FA Score has 0 green FA rating(s).

  • ACB’s FA Score: 0 green, 5 red.
  • SNDL’s FA Score: 0 green, 5 red.
According to our system of comparison, ACB is a better buy in the long-term than SNDL.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ACB’s TA Score shows that 6 TA indicator(s) are bullish while SNDL’s TA Score has 5 bullish TA indicator(s).

  • ACB’s TA Score: 6 bullish, 4 bearish.
  • SNDL’s TA Score: 5 bullish, 5 bearish.
According to our system of comparison, ACB is a better buy in the short-term than SNDL.

Price Growth

ACB (@Pharmaceuticals: Generic) experienced а -5.32% price change this week, while SNDL (@Beverages: Alcoholic) price change was -6.62% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Generic industry was -5.31%. For the same industry, the average monthly price growth was -4.84%, and the average quarterly price growth was +30.17%.

The average weekly price growth across all stocks in the @Beverages: Alcoholic industry was -4.53%. For the same industry, the average monthly price growth was -8.72%, and the average quarterly price growth was -20.17%.

Reported Earning Dates

ACB is expected to report earnings on Nov 11, 2026.

SNDL is expected to report earnings on Nov 10, 2026.

Industries' Descriptions

@Pharmaceuticals: Generic (-5.31% weekly)

A generic drug contains the same chemical substance as a drug that was originally protected by patents. Generic drugs are generally sold at cheaper price points, compared to name-brand pharmaceuticals, after patents for the more expensive drugs lapse. The generic drug industry has created a major market, thanks to the lower pricing. According to the Center for Justice and Democracy at New York Law School, 80 percent of all drugs prescribed are generic, and generic drugs are chosen 94 percent of the time when they are available. But their manufacturers must be able to prove to the FDA that they can be effective substitutes for the original drugs. Some of the major generic drug makers include Zoetis, Inc., Allergan plc and Mylan N.V.

@Beverages: Alcoholic (-4.53% weekly)

The alcoholic beverage market includes beer, wine, and spirits. From $230 billion in 2015, the industry has grown to around $250 billion by 2019. In recent years, alcoholic beverage makers have been looking to expand distribution and purchase channels, such as through online stores (e.g. e-commerce platform Drizly) and convenience stores. Anheuser-Busch In Bev and Diageo are major global alcoholic beverage companies, while U.S.-owned companies include Constellation Brands and Brown-Forman Corp. among several others.

View a ticker or compare two or three
ACB
Daily Signal:
Gain/Loss:
SNDL
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
OANWX27.500.13
+0.47%
Oakmark Global Select Institutional
FKEMX59.99N/A
N/A
Fidelity Emerging Markets K
WWWEX17.26N/A
N/A
Kinetics Global No Load
FMPTX36.37N/A
N/A
Fidelity Advisor Mid Cap Value M
PSLAX18.18N/A
N/A
Putnam Small Cap Value A

SNDL and

Correlation & Price change

A.I.dvisor indicates that over the last year, SNDL has been closely correlated with CGC. These tickers have moved in lockstep 77% of the time. This A.I.-generated data suggests there is a high statistical probability that if SNDL jumps, then CGC could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SNDL
1D Price
Change %
SNDL100%
N/A
CGC - SNDL
77%
Closely correlated
-0.25%
TLRY - SNDL
76%
Closely correlated
-2.90%
CRON - SNDL
73%
Closely correlated
-0.63%
OGI - SNDL
68%
Closely correlated
-1.87%
ACB - SNDL
65%
Loosely correlated
+0.27%
More